BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38448008)

  • 1. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
    Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
    Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.
    Cubo AM; Huélamo M; Martín-Seisdedos MC; Hernández-Hernández E; Lapresa-Alcalde MV; Rodríguez-Martín MO; Doyague MJ; Sayagués JM
    Fetal Diagn Ther; 2022; 49(3):103-113. PubMed ID: 35259749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.
    Bevilacqua E; Jani JC; Letourneau A; Duiella SF; Kleinfinger P; Lohmann L; Resta S; Cos Sanchez T; Fils JF; Mirra M; Benachi A; Costa JM
    Fetal Diagn Ther; 2019; 45(5):302-311. PubMed ID: 29898450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Review of Noninvasive Prenatal Testing: Experience from 551 Pregnancies with Noninvasive Prenatal Testing-Positive Results in a Tertiary Referral Center.
    Wu X; Li Y; Xie X; Su L; Cai M; Lin N; Du S; Xu L; Huang H
    J Mol Diagn; 2020 Dec; 22(12):1469-1475. PubMed ID: 33069877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.
    Rose NC; Barrie ES; Malinowski J; Jenkins GP; McClain MR; LaGrave D; Leung ML;
    Genet Med; 2022 Jul; 24(7):1379-1391. PubMed ID: 35608568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations.
    van Riel M; Brison N; Baetens M; Blaumeiser B; Boemer F; Bourlard L; Bulk S; De Leener A; Désir J; Devriendt K; Dheedene A; Duquenne A; Fieremans N; Fieuw A; Gatot JS; Grisart B; Janssens S; Khudashvili N; Lannoo L; Marichal A; Meunier C; Palmeira L; Parijs I; Pichon B; Roets E; Sammels E; Smits G; Suenaert M; Sznajer Y; Van den Bogaert K; Vancoillie L; Vandeputte L; Vantroys E; Vermeesch JR; Janssens K
    Obstet Gynecol; 2021 Jun; 137(6):1102-1108. PubMed ID: 33957658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.